Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
recombinant-iduronate-2-sulfatase (JR-032) / GSK, JCR Pharma
STARLIGHT, NCT04573023 / 2020-003200-14: A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II	Recruiting	3	80	Europe, US, RoW	JR-141, Idursulfase, JR-141 or Idursulfase	JCR Pharmaceuticals Co., Ltd., JCR Pharmaceuticals Co., Ltd.	Mucopolysaccharidosis II	01/26	01/26